Clinical Outcomes and Lack of Health Equity in Minority Patients with Unresectable Non-small Cell Lung Cancer (NSCLC) Treated with Durvalumab

被引：0
|
作者：
Fares, A. [1 ]
Theik, N. [2 ]
Dumais, K. [3 ]
Walker, D. [3 ]
Rodriguez, M. [1 ]
Dickson, F. [4 ]
Swaby, G. [5 ]
Alvarez, A. M. [3 ]
Raez, L. E. [3 ]
机构：
[1] Mem Canc Inst, Pembroke Pines, FL USA
[2] Mem Healthcare Syst, Pembroke Pines, FL USA
[3] Florida Atlantic Univ FAU, Mem Canc Inst, Pembroke Pines, FL USA
[4] BMS, Pembroke Pines, FL USA
[5] Mem Healthcare Syst, Pembroke Pines, GA USA
来源：
JOURNAL OF THORACIC ONCOLOGY | 2023年 / 18卷 / 11期
关键词：
Disparities; NSCLC; Immunotherapy;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
EP17.04-06
引用
收藏
页码：S741 / S741
页数：1
相关论文
共 50 条
  • [41] Potential clinical prognostic factors in non-small cell lung cancer (NSCLC) patients treated with gefitinib.
    Villaflor, VM
    Polowy, CR
    Coon, JS
    Leslie, WT
    Lukic, I
    Kanevsky, G
    Gale, M
    Stewart, I
    Bonomi, P
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 638S - 638S
  • [42] Clinical implications of mixed response on prognosis of non-small cell lung cancer (NSCLC) patients treated with Immunotherapy
    Lee, Seyoung
    Um, Taegyu
    Lee, Jeeyeon
    Kim, Peter Haseok
    Yadav, Monica
    Chuchuca, Maria J.
    Chung, Liam Il-Young
    Chae, Young Kwang
    CANCER RESEARCH, 2024, 84 (06)
  • [43] What is the place of clinical variables in advanced non-small cell lung cancer (NSCLC) patients treated with chemotherapy?
    Berhoune, M.
    Fabre-Guillevin, E.
    Banu, E.
    Scotte, F.
    Bonan, B.
    Medioni, J.
    Cojocarasu, O.
    Rideller, K.
    Ayllon, J.
    Levy, E.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [44] Potential clinical prognostic factors in non-small cell lung cancer (NSCLC) patients treated with Gefitinib (Iressa)
    Villaflor, VM
    Polowy, CR
    Coon, J
    Leslie, W
    Lukic, I
    Kanevsky, G
    Gale, M
    Stewart, I
    Bonomi, P
    LUNG CANCER, 2004, 46 : S62 - S62
  • [45] Non-small cell lung cancer (NSCLC) in elderly patients
    Batura-Gabryel, H.
    Brajer, B.
    LUNG CANCER, 2006, 52 : S19 - S19
  • [46] Impact of radiation on host immune system in patients treated with chemoradiotherapy and durvalumab consolidation for unresectable locally advanced non-small cell lung cancer
    Pasquier, Corentin
    Chaltiel, Leonor
    Massabeau, Carole
    Rabeau, Audrey
    Lebas, Louisiane
    Lusque, Amelie
    Texier, Jean-Sebastien
    Moyal, Elizabeth Cohen-Jonathan
    Mazieres, Julien
    Khalifa, Jonathan
    FRONTIERS IN ONCOLOGY, 2023, 13
  • [47] LOCAL-REGIONAL NON-SMALL CELL LUNG CANCER - BIOMARKERS IN UNRESECTABLE NSCLC
    Hopkins, B.
    Luca, K.
    Roper, J.
    Ridge, N.
    Sebastian, N.
    Kesarwala, A. H.
    Shelton, J.
    Stokes, W.
    Tian, S.
    JOURNAL OF THORACIC ONCOLOGY, 2024, 19 (10) : S567 - S567
  • [48] Korean Real-world Data on Unresectable Stage III Non-Small Cell Lung Cancer Patients Treated with Durvalumab after Chemoradiotherapy
    Oh, H. -J.
    Park, C. -K.
    Kim, Y. -C.
    Kim, Y. -H.
    Ahn, S. -J.
    Jeong, W. G.
    Lee, J. Y.
    Lee, J. C.
    Choi, C. M.
    Ji, W.
    Song, S. Y.
    Choi, J.
    Lee, S. Y.
    Kim, H.
    Lee, S. Y.
    Park, J.
    Yoon, S. H.
    Joo, J. H.
    Oh, I. -J.
    JOURNAL OF THORACIC ONCOLOGY, 2023, 18 (11) : S294 - S295
  • [49] Association between the lung immune prognostic index (LIPI) and durvalumab consolidation outcomes in patients with locally advanced non-small cell lung cancer (NSCLC)
    Melia, M. Riudavets
    Auclin, E.
    Aboubakar, F.
    Aix, S. Ponce
    Dal Maso, A.
    Bluthgen, V.
    Mielgo, X.
    Mussat, E.
    Reyes, R.
    Benitez, J.
    Lupinacci, L.
    Duchemann, B.
    de Giglio, A.
    Bautista, J.
    Audigier-Valette, C.
    Scheffler, M.
    Campayo, M.
    Besse, B.
    Planchard, D.
    Mezquita, L.
    ANNALS OF ONCOLOGY, 2021, 32 : S1384 - S1384
  • [50] Plunging Into the PACIFIC: Outcomes of Patients With Unresectable KRAS-Mutated Non-Small Cell Lung Cancer Following Definitive Chemoradiation and Durvalumab Consolidation
    Barsouk, Adam
    Friedes, Cole
    Iocolano, Michelle
    Doucette, Abigail
    Cohen, Roger B.
    Robinson, Kyle W.
    D'Avella, Christopher A.
    Marmarelis, Melina E.
    Kosteva, John A.
    Singh, Aditi P.
    Ciunci, Christine A.
    Levin, William P.
    Cengel, Keith A.
    Bradley, Jeffrey D.
    Feigenberg, Steven J.
    Sun, Lova
    Aggarwal, Charu
    Langer, Corey J.
    Yegya-Raman, Nikhil
    CLINICAL LUNG CANCER, 2024, 25 (03) : e161 - e171
12345